1 Min Read
Jan 16 (Reuters) - BAYER AG:
* FDA REPORT REAFFIRMS SAFETY PROFILE AND EFFECTIVENESS OF BAYER'S XARELTO IN ROUTINE CLINICAL PRACTICE Source text: bit.ly/2DDuMIB Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.